Group Sequential Clinical Trials: A Classical Evaluation of Bayesian Decision-Theoretic Designs
组序贯临床试验:贝叶斯决策论设计的经典统计评价AI 解读 ↓
本页整理公开书目信息,不生成学术质量评分。AI 解读根据题名及所注明的摘要或原文片段生成,未完成全文核验,可能有误;具体假设、证明与结论请核对原文。摘要保留来源文本,未经模型改写。
DOI 首次登记不等于接收或发表日期。部分更正、评论等条目没有独立摘要;缺少可靠材料时保留待补状态。
引用量采用 OpenAlex 单条关联记录,不合计多个记录;关联记录可能包含正式发表版本,不等于此版本单独引用。缺失不视为零,引用指标不代表论文质量。
关注作者按书目中的完整姓名匹配,同名和姓名变体需人工辨别。相关论文先按共享细分方向和具体方法排列,再参考通用方法与发表日期。
AI 根据所提供的论文材料归类:摘要研究临床组序贯检验与决策成本,治疗比较本身不足以归入因果推断细分。
组序贯临床试验:贝叶斯决策论设计的经典统计评价AI 解读 ↓
正在核对关联版本…
正在核对对应版本的资源…
Bayesian decision-theoretic designs for a clinical trial comparing two treatments for a disease with binary outcomes are developed and evaluated. The probability of successful outcome with treatment i is denoted by pi , i = 1, 2, and prior knowledge regarding each pi is assumed to follow a beta distribution. The pi are assumed to be independent. To facilitate comparison with frequentist clinical trial designs, we take a hypothesis-testing approach. The null hypothesis is δ < δ 0, and the alternative hypothesis is δ > 0, where δ 0 is the minimum treatment effect sought by the trial and δ = p 2 - p 1 is the true treatment difference. We use a simple terminal loss function reflecting the hypothesis-testing goal of the trial, and the total cost of the trial is the final sample size plus the terminal loss function. The stopping and decision rules that minimize the expectation of the total cost are determined by backward induction. Monte Carlo simulation is used to compare Bayesian and frequentist error rates and mean sample sizes of these Bayesian designs with one-tailed classical group-sequential designs of Pocock and O'Brien-Fleming. As expected, the Bayesian decision-theoretic designs have smaller mean costs than the classical designs. More surprising, when the magnitude of the terminal loss function is chosen to yield frequentist error rates similar to those for classical designs, the mean sample sizes of the Bayesian designs are usually smaller.